We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for concizumab (Novo Nordisk Pharmaceuticals Pty Ltd)
Active ingredients
concizumab
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Solution for subcutaneous injection
Indication
For the treatment of haemophilia B
Therapeutic area
Haematology